C. Bourgier

4.9k total citations · 1 hit paper
163 papers, 3.1k citations indexed

About

C. Bourgier is a scholar working on Cancer Research, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, C. Bourgier has authored 163 papers receiving a total of 3.1k indexed citations (citations by other indexed papers that have themselves been cited), including 94 papers in Cancer Research, 73 papers in Oncology and 49 papers in Pulmonary and Respiratory Medicine. Recurrent topics in C. Bourgier's work include Breast Cancer Treatment Studies (86 papers), Advanced Radiotherapy Techniques (45 papers) and Breast Lesions and Carcinomas (32 papers). C. Bourgier is often cited by papers focused on Breast Cancer Treatment Studies (86 papers), Advanced Radiotherapy Techniques (45 papers) and Breast Lesions and Carcinomas (32 papers). C. Bourgier collaborates with scholars based in France, Italy and Switzerland. C. Bourgier's co-authors include D. Azria, Marie‐Catherine Vozenin, H. Marsiglia, Suzette Delaloge, Claire Cropet, Marc Debled, Éric Legouffe, Claude El Kouri, Valérie Haydont and Dominique Spaëth and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Cancer Research.

In The Last Decade

C. Bourgier

155 papers receiving 3.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Randomized Phase II Trial of Everolimus in Combination With Tamoxifen in Patients With Hormone Receptor–Positive, Human Epidermal Growth Factor Receptor 2–Negative Metastatic Breast Cancer With Prior Exposure to Aromatase Inhibitors: A GINECO Study

2012 539 citations Thomas Bachelot, C. Bourgier et al. Journal of Clinical Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
C. Bourgier France	31	1.2k	1.2k	1.1k	791	649	163	3.1k
Marc A. Bollet France	31	1.2k 1.0×	1.6k 1.3×	569 0.5×	386 0.5×	540 0.8×	103	2.9k
Doo Ho Choi South Korea	30	1.4k 1.1×	1.0k 0.8×	709 0.7×	372 0.5×	461 0.7×	184	2.9k
A. Courdi France	25	1.0k 0.8×	889 0.7×	696 0.6×	501 0.6×	591 0.9×	85	2.7k
Ruth Heimann United States	25	970 0.8×	1.1k 0.9×	684 0.6×	260 0.3×	908 1.4×	69	2.8k
Gillian C. Barnett United Kingdom	22	535 0.4×	684 0.6×	728 0.7×	994 1.3×	465 0.7×	41	2.1k
Birgitte Vrou Offersen Denmark	32	986 0.8×	2.3k 1.9×	684 0.6×	901 1.1×	334 0.5×	125	3.3k
Günther Gruber Switzerland	15	1.7k 1.3×	1.8k 1.5×	556 0.5×	548 0.7×	513 0.8×	24	3.2k
F. Pozza Italy	20	1.2k 1.0×	1.3k 1.1×	654 0.6×	594 0.8×	1.6k 2.5×	62	4.1k
Francisco Perera Canada	26	1.2k 0.9×	2.1k 1.7×	570 0.5×	694 0.9×	147 0.2×	53	3.2k
Xiaomao Guo China	28	769 0.6×	633 0.5×	731 0.7×	412 0.5×	502 0.8×	115	2.2k

Countries citing papers authored by C. Bourgier

Since Specialization

Citations

This map shows the geographic impact of C. Bourgier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. Bourgier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. Bourgier more than expected).

Fields of papers citing papers by C. Bourgier

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C. Bourgier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. Bourgier. The network helps show where C. Bourgier may publish in the future.

Co-authorship network of co-authors of C. Bourgier

This figure shows the co-authorship network connecting the top 25 collaborators of C. Bourgier. A scholar is included among the top collaborators of C. Bourgier based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C. Bourgier. C. Bourgier is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Bourgier, C., et al.. (2024). 976: Feasibility study of adaptive radiotherapy with Ethos for breast cancer. Radiotherapy and Oncology. 194. S4210–S4212. 1 indexed citations

Mora, Laura, et al.. (2024). Evaluation of Ethos intelligent optimization engine for left locally advanced breast cancer. Frontiers in Oncology. 14. 1399978–1399978.

Bourgier, C., et al.. (2024). Committee of the new positions of the Société française de radiothérapie oncologique: Toward an advanced practice master in radiotherapy. Cancer/Radiothérapie. 28(6-7). 560–564.

Racadot, S., et al.. (2023). Radiothérapie des cancers du sein : questions d’actualité en 2023. Cancer/Radiothérapie. 27(6-7). 524–530. 1 indexed citations

Bourgier, C., Émilie Bayart, J. Chamois, et al.. (2023). Métier de manipulateur en radiothérapie en tension en France : conséquences organisationnelles et difficultés à déployer de nouvelles missions et/ou délégation de tâches. Cancer/Radiothérapie. 27(6-7). 577–582. 1 indexed citations

Fenoglietto, P., Sophie Gourgou, C. Lemanski, et al.. (2022). Efficacy, safety, and feasibility of volumetric modulated arc therapy for synchronous bilateral breast cancer management. Frontiers in Oncology. 12. 967479–967479. 2 indexed citations

Fraisse, Julien, Marta Jarlier, Florence Boissière‐Michot, et al.. (2020). Higher Anti-Tumor Efficacy of the Dual HER3-EGFR Antibody MEHD7945a Combined with Ionizing Irradiation in Cervical Cancer Cells. International Journal of Radiation Oncology*Biology*Physics. 106(5). 1039–1051. 8 indexed citations

Mollévi, Caroline, C. Bourgier, Thierry Conroy, et al.. (2020). Longitudinal analysis of health-related quality of life in cancer clinical trials: methods and interpretation of results. Quality of Life Research. 30(1). 91–103. 10 indexed citations

Maran-Gonzalez, Aurélie, Marie Viala, Nelly Firmin, et al.. (2019). <p>Decision of Adjuvant Systemic Treatment in HR+ HER2- Early Invasive Breast Cancer: Which Biomarkers Could Help?</p>. Cancer Management and Research. Volume 11. 10353–10373. 4 indexed citations

10.

Riou, O., C. Bourgier, Muriel Brengues, et al.. (2019). Outils pour la prédiction de la réponse tumorale et des tissus sains en oncologie radiothérapie. Cancer/Radiothérapie. 23(6-7). 666–673. 4 indexed citations

11.

Arriagada, R., Marcos Santos, C. Bourgier, et al.. (2017). Preoperative radiotherapy in breast cancer patients: 32 years of follow-up. European Journal of Cancer. 76. 45–51. 31 indexed citations

12.

Bourgier, C., C. Lemanski, O. Riou, et al.. (2013). Irradiation hypofractionnée à visée curative, standard thérapeutique des cancers du sein ?. Cancer/Radiothérapie. 17(7). 705–707. 6 indexed citations

13.

Bachelot, Thomas, C. Bourgier, Claire Cropet, et al.. (2012). Randomized Phase II Trial of Everolimus in Combination With Tamoxifen in Patients With Hormone Receptor–Positive, Human Epidermal Growth Factor Receptor 2–Negative Metastatic Breast Cancer With Prior Exposure to Aromatase Inhibitors: A GINECO Study. Journal of Clinical Oncology. 30(22). 2718–2724. 539 indexed citations breakdown →

14.

Guerra, José Luis López, et al.. (2012). New perspectives in radiation oncology: Young radiation oncologist point of view and challenges. Reports of Practical Oncology & Radiotherapy. 17(5). 251–254. 14 indexed citations

15.

Sole, Claudio V., R. Matute, J. Jaén, et al.. (2012). Stereotactic ablative radiotherapy delivered by image-guided helical tomotherapy for extracranial oligometastases. Clinical & Translational Oncology. 15(6). 484–491. 10 indexed citations

16.

Balleyguier, Corinne, Sandra Canale, Wagih Ben Hassen, et al.. (2012). Breast elasticity: Principles, technique, results: An update and overview of commercially available software. European Journal of Radiology. 82(3). 427–434. 102 indexed citations

17.

Bourgier, C., Antonin Lévy, Marie‐Catherine Vozenin, & Éric Deutsch. (2012). Pharmacological strategies to spare normal tissues from radiation damage: useless or overlooked therapeutics?. Cancer and Metastasis Reviews. 31(3-4). 699–712. 36 indexed citations

18.

Bourgier, C., Virginie Monceau, Jean Bourhis, Éric Deutsch, & Marie‐Catherine Vozenin. (2011). Modulation pharmacologique des effets tardifs de l’irradiation. Cancer/Radiothérapie. 15(5). 383–389. 6 indexed citations

19.

Pichenot, C., Ariane Dunant, Corinne Balleyguier, et al.. (2009). Surgical Clips Assist in the Visualization of the Lumpectomy Cavity in Three-Dimensional Conformal Accelerated Partial-Breast Irradiation. International Journal of Radiation Oncology*Biology*Physics. 76(5). 1320–1324. 55 indexed citations

20.

Haydont, Valérie, O. Gilliot, Sofía Rivera, et al.. (2007). Successful Mitigation of Delayed Intestinal Radiation Injury Using Pravastatin is not Associated with Acute Injury Improvement or Tumor Protection. International Journal of Radiation Oncology*Biology*Physics. 68(5). 1471–1482. 49 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact